ISSN 1300-4948 | E-ISSN 2148-5607
Review
Liver fibrosis
1 Mikrogen Genetic Diagnostic Laboratory, Ankara, Turkey  
2 Department of Biophysics, Ankara University, School of Medicine, Ankara, Turkey  
Turk J Gastroenterol 2018; 29: 13-20
DOI: 10.5152/tjg.2018.18330
This article was viewed 0 times, downloaded 0 times

Key Words: Fibrosis, liver, MMPs, experimental models
Abstract

Liver fibrosis is a wound-healing response generated against an insult to the liver that causes liver injury. It has the potential to progress into cirrhosis, and if not prevented, it may lead to liver cancer and liver failure. The activation of hepatic stellate cells (HSCs) is the central event underlying liver fibrosis. In addition to HSCs, numerous studies have supported the potential contribution of bone marrow-derived cells and myofibroblasts to liver fibrosis. The liver is a heterogeneous organ; thus, molecular and cellular events that underlie liver fibrogenesis are complex. This review aims to focus on major events that occur during liver fibrogenesis. In addition, important antifibrotic therapeutic approaches and experimental liver fibrosis models will be discussed.

 

 

Cite this article as: Aydın MM, Akçalı KC. Liver fibrosis. Turk J Gastroenterol 2018; 29: 13-20.

Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2017 Turkish Society of Gastroenterology | Latest Update: 11.01.2018